Surgical Therapy of Primary Aldosteronism

J. Hauss; W. Vetter; Manfred M. Fischer; H. Vetter

doi:10.1007/978-3-642-69081-5_19

Chapter in a book2001

Clinical Presentation and Diagnosis of Cushing’s Syndrome

Andrew N. Margioris, George Chrousos

Article2013

Evidence of Primary Aldosteronism in a Predominantly Female Cohort of Normotensive Individuals: A Very High Odds Ratio for Progression into Arterial Hypertension

Αthina Markou, Θεοδώρα Παππά, Gregory Kaltsas, Aggeliki Gouli, Kostas Mitsakis, Panayiotis Tsounas, Anastasia Prevoli, Vaios Tsiavos, Labrini Papanastasiou, George Zografos, George Chrousos, George Piaditis

Article1990

Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis.

Adi F. Gazdar, Herbert K. Oie, Cedric Shackleton, T. R. Chen, Timothy J. Triche, Charles E. Myers, George Chrousos, Murray F. Brennan, C. A. Stein, Renato V. La Rocca

Article2014

Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?

Paolo Cravedi, Giuseppe Remuzzi, Piero Ruggenenti

Article1994

Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy.

Keiko Arai, C. Tsigos, Yoshiyuki Suzuki, Ilan Irony, Michael Karl, S J Listwak, George Chrousos

Surgical Therapy of Primary Aldosteronism

Abstract

Discussion(0)

Related publications

Clinical Presentation and Diagnosis of Cushing’s Syndrome

Evidence of Primary Aldosteronism in a Predominantly Female Cohort of Normotensive Individuals: A Very High Odds Ratio for Progression into Arterial Hypertension

Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis.

Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?

Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy.